UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GP120: target for neutralizing HIV-1 antibodies

Annual Review of Immunology, 2006-01, Vol.24 (1), p.739-769

2006

Volltextzugriff (PDF)

Antibody epitope exposure and neutralization of HIV-1

Current pharmaceutical design, 2010-11, Vol.16 (33), p.3729-3743

Pantophlet, Ralph

2010

Volltextzugriff (PDF)

Synthesis of an Undecasaccharide Featuring an Oligomannosidic Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting Neutralizing Antibodies to Mammalian Oligomannose on the HIV‑1 Envelope Spike

Journal of the American Chemical Society, 2019-05, Vol.141 (19), p.7946-7954

2019

Volltextzugriff (PDF)

Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity

Nature communications, 2017-11, Vol.8 (1), p.1601-12, Article 1601

2017

Volltextzugriff (PDF)

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

The Journal of infectious diseases, 2022-09, Vol.226 (6), p.983-994

2022

Volltextzugriff (PDF)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

npj vaccines, 2022-02, Vol.7 (1), p.28-12, Article 28

2022

Volltextzugriff (PDF)

Synthesis of a Pentasaccharide Fragment Related to the Inner Core Region of Rhizobial and Agrobacterial Lipopolysaccharides

Journal of organic chemistry, 2017-12, Vol.82 (23), p.12346-12358

2017

Volltextzugriff (PDF)

A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Scientific reports, 2021-02, Vol.11 (1), p.4637-12, Article 4637

2021

Volltextzugriff (PDF)

Crystal Structure of a Neutralizing Human IgG against HIV-1: A Template for Vaccine Design

Science (American Association for the Advancement of Science), 2001-08, Vol.293 (5532), p.1155-1159

2001

Volltextzugriff (PDF)

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Journal of Virology, 2007-06, Vol.81 (12), p.6548-6562

2007

Volltextzugriff (PDF)

Effect of buffer composition on PNA–RNA hybridization studied in the microfluidic microarray chip

Canadian journal of chemistry, 2018-02, Vol.96 (2), p.241-247

2018

Volltextzugriff (PDF)

Binding of the Mannose-Specific Lectin, Griffithsin, to HIV-1 gp120 Exposes the CD4-Binding Site

Journal of Virology, 2011-09, Vol.85 (17), p.9039-9050

2011

Volltextzugriff (PDF)

A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120

Journal of Virology, 2008-07, Vol.82 (13), p.6359-6368

2008

Volltextzugriff (PDF)

Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120

Journal of Virology, 2003-01, Vol.77 (1), p.642-658

2003

Volltextzugriff (PDF)

HIV-1 Entry and Prospects for Protecting against Infection

Microorganisms (Basel), 2021-01, Vol.9 (2), p.228

2021

Volltextzugriff (PDF)

Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual

PloS one, 2015-05, Vol.10 (5), p.e0125575-e0125575

2015

Volltextzugriff (PDF)

N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization

Journal of Virology, 2007-10, Vol.81 (19), p.10769-10776

2007

Volltextzugriff (PDF)

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

Journal of Virology, 2003-05, Vol.77 (10), p.5889-5901

2003

Volltextzugriff (PDF)

Comparing Antigenicity and Immunogenicity of Engineered gp120

Journal of Virology, 2005-10, Vol.79 (19), p.12148-12163

2005

Volltextzugriff (PDF)

Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis

Virology (New York, N.Y.), 2007-08, Vol.364 (2), p.441-453

2007

Volltextzugriff (PDF)

2G12-Expressing B Cell Lines May Aid in HIV Carbohydrate Vaccine Design Strategies

Journal of Virology, 2013-02, Vol.87 (4), p.2234-2241

2013

Volltextzugriff (PDF)

The Human Immunodeficiency Virus Type 1 Envelope Spike of Primary Viruses Can Suppress Antibody Access to Variable Regions

Journal of Virology, 2009-02, Vol.83 (4), p.1649-1659

2009

Volltextzugriff (PDF)

A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation

Journal of Virology, 2004-12, Vol.78 (24), p.14012-14022

2004

Volltextzugriff (PDF)

Comparative Antigenicity of Thiourea and Adipic Amide Linked Neoglycoconjugates Containing Modified Oligomannose Epitopes for the Carbohydrate-Specific anti-HIV Antibody 2G12

Bioconjugate chemistry, 2019-01, Vol.30 (1), p.70-82

2019

Volltextzugriff (PDF)

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

The Journal of infectious diseases, 2022-04, Vol.225 (7), p.1129-1140

2022

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(66)
Berichte
(1)

Sprache

Englisch
(67)
Japanisch
(10)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

GP120: target for neutralizing HIV-1 antibodies

Antibody epitope exposure and neutralization of HIV-1

Synthesis of an Undecasaccharide Featuring an Oligomannosidic Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting Neutralizing Antibodies to Mammalian Oligomannose on the HIV‑1 Envelope Spike

Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

Synthesis of a Pentasaccharide Fragment Related to the Inner Core Region of Rhizobial and Agrobacterial Lipopolysaccharides

A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Crystal Structure of a Neutralizing Human IgG against HIV-1: A Template for Vaccine Design

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Effect of buffer composition on PNA–RNA hybridization studied in the microfluidic microarray chip

Binding of the Mannose-Specific Lectin, Griffithsin, to HIV-1 gp120 Exposes the CD4-Binding Site

A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120

Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120

HIV-1 Entry and Prospects for Protecting against Infection

Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual

N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

Comparing Antigenicity and Immunogenicity of Engineered gp120

Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis

2G12-Expressing B Cell Lines May Aid in HIV Carbohydrate Vaccine Design Strategies

The Human Immunodeficiency Virus Type 1 Envelope Spike of Primary Viruses Can Suppress Antibody Access to Variable Regions

A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation

Comparative Antigenicity of Thiourea and Adipic Amide Linked Neoglycoconjugates Containing Modified Oligomannose Epitopes for the Carbohydrate-Specific anti-HIV Antibody 2G12

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

Suchergebnisse filtern